Bedel Financial Consulting’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,160
Closed -$207K 302
2025
Q4
$207K Sell
2,160
-70
-3% -$6.8K 0.02% 279
2025
Q3
$212K Buy
+2,230
New +$205K 0.03% 270
2022
Q2
Sell
-1,119
Closed -$124K 594
2022
Q1
$124K Sell
1,119
-136
-11% -$14.4K 0.04% 241
2021
Q4
$130K Sell
1,255
-65
-5% -$7.53K 0.04% 240
2021
Q3
$165K Hold
1,320
0.06% 204
2021
Q2
$164K Buy
1,320
+180
+16% +$22.6K 0.06% 201
2021
Q1
$135K Buy
1,140
+21
+2% +$2.46K 0.05% 218
2020
Q4
$131K Hold
1,119
0.06% 192
2020
Q3
$116K Hold
1,119
0.06% 191
2020
Q2
$103K Sell
1,119
-933
-45% -$89.5K 0.06% 197
2020
Q1
$185K Buy
2,052
+22
+1% +$2.34K 0.12% 125
2019
Q4
$230K Hold
2,030
0.13% 125
2019
Q3
$220K Buy
2,030
+53
+3% +$5.53K 0.13% 131
2019
Q2
$193K Hold
1,977
0.12% 140
2019
Q1
$180K Hold
1,977
0.11% 138
2018
Q4
$180K Hold
1,977
0.13% 128
2018
Q3
$190K Sell
1,977
-406
-17% -$37.5K 0.13% 139
2018
Q2
$204K Sell
2,383
-17
-0.7% -$1.42K 0.15% 133
2018
Q1
$193K Buy
+2,400
New +$198K 0.15% 136

Other funds holding MDT

Bedel Financial Consulting's MDT Position: Q1 2026 in Review

Bedel Financial Consulting sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,160 shares — an estimated $207K sold.

Bedel Financial Consulting first reported a position in MDT in Q1 2018 and held it in 19 quarters. The position peaked at $230K in Q4 2019. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Bedel Financial Consulting reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Bedel Financial Consulting sold 2,160 Medtronic shares in Q1 2026, an estimated $207K.
  • Bedel Financial Consulting first reported a position in Medtronic in Q1 2018 and held it in 19 quarters.
  • Bedel Financial Consulting's Medtronic position peaked at $230K in Q4 2019.
  • 2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Bedel Financial Consulting's 13F filing for Q1 2026, filed 4 May 2026.